(0)
Overview: This paper discusses some of the drivers behind the increasing number of pharmaceutical and biotechnology companies moving from traditional proprietary chemical information systems into modern alternatives. The paper explores the business drivers for change and discusses some of the issues which must be considered before migrating chemical information, including an analysis of common issues. New approaches such as systems biology and translational medicine demand interoperability and integration of data and systems. Oracle data cartridge technology offers the opportunity to break the dependency between a pharmaceutical companys data and the software that manages it, encouraging an increase in the utilization and value of data.
Bay Area Internet Solutions
As Bay Area Internet Solutions was quickly becoming an established player in Silicon Valley’s managed services industry, the company’s global customer base—startups to Fortune 500 companies—was...
Learn how innovative thinking can benefit your data center
In this white paper from The Bathwick Group, courtesy of IBM, you’ll learn the role of innovation in the data center.
|
